Cargando…
Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test
On 11 March 2020, WHO declared the SARS-CoV-2 outbreak as a pandemic, representing a public health emergency of unprecedented dimension. COVID-19 is a multisystem Novel viral infection with protean manifestations and variable degrees of clinical presentation. The most common presentation is upper an...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089408/ http://dx.doi.org/10.1159/000514069 |
_version_ | 1783687039600820224 |
---|---|
author | Abdelrahman, Oghowan Shadan, Andleeb Al Dabal, Laila Keloth, Tasnim R. |
author_facet | Abdelrahman, Oghowan Shadan, Andleeb Al Dabal, Laila Keloth, Tasnim R. |
author_sort | Abdelrahman, Oghowan |
collection | PubMed |
description | On 11 March 2020, WHO declared the SARS-CoV-2 outbreak as a pandemic, representing a public health emergency of unprecedented dimension. COVID-19 is a multisystem Novel viral infection with protean manifestations and variable degrees of clinical presentation. The most common presentation is upper and lower respiratory tract illness. Cutaneous manifestations of COVID-19 have rarely been described. In this case report, we present a 41-year-old male patient who presented with fatigue and follicular skin rash followed almost 2 weeks later with fever, left upper limb transient weakness, and pneumonia. Of interest is that the patient's skin lesions tested positive on COVID-19 antigen test. The patient received a course of anti-COVID-19 treatment as per our national guideline, and he made a full clinical and radiology recovery. |
format | Online Article Text |
id | pubmed-8089408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-80894082021-05-03 Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test Abdelrahman, Oghowan Shadan, Andleeb Al Dabal, Laila Keloth, Tasnim R. Dubai Medical Journal Educational Corner − Case Report On 11 March 2020, WHO declared the SARS-CoV-2 outbreak as a pandemic, representing a public health emergency of unprecedented dimension. COVID-19 is a multisystem Novel viral infection with protean manifestations and variable degrees of clinical presentation. The most common presentation is upper and lower respiratory tract illness. Cutaneous manifestations of COVID-19 have rarely been described. In this case report, we present a 41-year-old male patient who presented with fatigue and follicular skin rash followed almost 2 weeks later with fever, left upper limb transient weakness, and pneumonia. Of interest is that the patient's skin lesions tested positive on COVID-19 antigen test. The patient received a course of anti-COVID-19 treatment as per our national guideline, and he made a full clinical and radiology recovery. S. Karger AG 2021-04-06 /pmc/articles/PMC8089408/ http://dx.doi.org/10.1159/000514069 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Educational Corner − Case Report Abdelrahman, Oghowan Shadan, Andleeb Al Dabal, Laila Keloth, Tasnim R. Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title | Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title_full | Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title_fullStr | Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title_full_unstemmed | Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title_short | Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test |
title_sort | leukocytoclastic vasculitis as a cutaneous manifestation of covid-19 infection with a positive skin antigen test |
topic | Educational Corner − Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089408/ http://dx.doi.org/10.1159/000514069 |
work_keys_str_mv | AT abdelrahmanoghowan leukocytoclasticvasculitisasacutaneousmanifestationofcovid19infectionwithapositiveskinantigentest AT shadanandleeb leukocytoclasticvasculitisasacutaneousmanifestationofcovid19infectionwithapositiveskinantigentest AT aldaballaila leukocytoclasticvasculitisasacutaneousmanifestationofcovid19infectionwithapositiveskinantigentest AT kelothtasnimr leukocytoclasticvasculitisasacutaneousmanifestationofcovid19infectionwithapositiveskinantigentest |